Skip to content
Screener

PP&E (Net) at other companies

TEC
Bio-TechneTECH
$232.99M-7.5%
Bruker logo
BrukerBRKR
$714.1M-5.9%
Illumina logo
IlluminaILMN
$745M-2.5%
Agilent Technologies logo
Agilent TechnologiesA
$2.1B+9.8%
Quanterix Corporation logo
Quanterix CorporationQTRX
$21.37M+29.8%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$527.5M-0.2%

Other financials

Income statement

See full
Revenue$151.0M-12.6%
Gross profit$112.5M-10.1%
Operating income-$19.6M-165%
Net income-$17.9M-152%
EPS (diluted)-$0.14-150%

Balance sheet

See full
Cash & equivalents$502.5M+26.4%
Total debt$78.8M-9.2%
Total equity$825.5M+6.8%
Total assets$1.0B+5.1%

Cash flow

See full
Operating cash flow$17.0M-4.1%
CapEx$1.6M+0.6%
Free cash flow$15.4M-4.6%

Valuation

See full
Market cap$5.79B+271%
Enterprise value$5.37B+330%
P/S9.4×+7.0×

Profitability

See full
Gross margin70%+0.5pp
Operating margin-14.3%-1.1pp
Net margin-12.2%-0.8pp
FCF margin19.7%+10.9pp

Returns & leverage

See full
Return on equity-9.4%-1.4pp
Debt / equity0.1×0.0×
Current ratio5.7×-0.1×

Where this comes from

Reported directly by 10x Genomics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026.

Filed
Aug 6, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054491
Line itemJune 30,2026December 31,2025
Inventory52,61656,341
Prepaid expenses and other current assets19,39322,208
Total current assets674,671684,451
Property and equipment, net215,324226,711
Operating lease right-of-use assets56,68560,450
Goodwill6,9184,511
Intangible assets, net61,16062,329
Other noncurrent assets15,3082,913

Item 1. Financial Statements (Unaudited)

FAQ

What is 10x Genomics, Inc.'s PP&E (net)?
10x Genomics, Inc. (TXG) reported PP&E (net) of $215.32M in Q2 2026.
How has 10x Genomics, Inc.'s PP&E (net) changed year-over-year?
10x Genomics, Inc.'s PP&E (net) decreased by 10.2% year-over-year, from $239.71M to $215.32M.
What is the long-term trend for 10x Genomics, Inc.'s PP&E (net)?
Over 5 years (2020 to 2025), 10x Genomics, Inc.'s PP&E (net) has grown at a 25.5% compound annual growth rate (CAGR), from $72.84M to $226.71M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Ask your AI about 10x Genomics, Inc.'s pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude